AquaBounty Technologies with ticker code (AQB) have now 4 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The range between the high target price and low target price is between 5 and 1.79 and has a mean target at 3.45. Now with the previous closing price of 1.14 this is indicating there is a potential upside of 202.6%. The 50 day moving average now sits at 0.81 and the 200 day MA is 1.11. The company has a market capitalisation of $80m. Find out more information at: https://www.aquabounty.com
The potential market cap would be $241m based on the market concensus.
AquaBounty Technologies, a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms and changed its name to AquaBounty Technologies in June 2004. AquaBounty Technologies was incorporated in 1991 and is headquartered in Maynard, Massachusetts.
